Gritstone Downgraded by Jones, B. Riley Over Cancer Vaccine Data
A Quick Look at Today's Ratings for Gritstone Bio(GRTS.US), With a Forecast Between $1 to $1
Key Takeaways From Gritstone Bio Analyst Ratings
Gritstone Bio Cut to Market Perform From Market Outperform by JMP Securities
JMP Securities Maintains Gritstone Bio(GRTS.US) With Hold Rating
JMP Securities Downgrades Gritstone Bio(GRTS.US) to Hold Rating
JMP Securities Maintains Gritstone Bio(GRTS.US) With Buy Rating, Maintains Target Price $5
Gritstone Bio Analyst Ratings
H.C. Wainwright Maintains Gritstone Bio(GRTS.US) With Buy Rating, Maintains Target Price $4
JMP Securities Maintains Gritstone Bio(GRTS.US) With Buy Rating, Maintains Target Price $5
TD Cowen Maintains Gritstone Bio(GRTS.US) With Buy Rating
Gritstone Bio Analyst Ratings
H.C. Wainwright Maintains Gritstone Bio(GRTS.US) With Buy Rating, Maintains Target Price $4
JMP Securities Maintains Gritstone Bio(GRTS.US) With Buy Rating, Maintains Target Price $5
Gritstone Bio Analyst Ratings
Gritstone Bio Analyst Ratings
B. Riley Cuts Price Target on Gritstone Bio to $3 From $6, Keeps Buy Rating
Gritstone Bio Analyst Ratings
Gritstone Bio Analyst Ratings
Gritstone Bio Analyst Ratings